Rima Al-awar
Directeur/Membre du Conseil chez SATELLOS BIOSCIENCE INC.
Fortune : - $ au 31/05/2024
Profil
Rima Al-awar is currently the Director at Satellos Bioscience, Inc. and has been a Member at Ontario Institute for Cancer Research since 2008.
She holds a doctorate degree from North Carolina State University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
SATELLOS BIOSCIENCE INC
-.--% | 29/05/2023 | 0 ( -.--% ) | - $ | 31/05/2024 |
Postes actifs de Rima Al-awar
Sociétés | Poste | Début |
---|---|---|
SATELLOS BIOSCIENCE INC. | Directeur/Membre du Conseil | 05/12/2021 |
Ontario Institute for Cancer Research
Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | Corporate Officer/Principal | 01/01/2008 |
Formation de Rima Al-awar
North Carolina State University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
SATELLOS BIOSCIENCE INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Ontario Institute for Cancer Research
Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | Health Services |